With new drugs in the pipeline and the impact of updated FDA drug safety policies on colchicine, gout may no longer be inexpensive to treat.
Lauren Meyer, PharmD
Advertisement
Articles by Lauren Meyer, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
2
GLP-1s and Oncology: The Drug Interaction Clinicians Aren't Talking About
3
The Weekly Dose: Cyclosporiasis Outbreak Grows, AI-Powered Refills Pilot, and New FDA Approvals in Alzheimer Disease, Oncology
4
Improving Detection and Management of ATTR-CM Through Pharmacy Care
5